A Randomized, Double-Blind, Placebo-Controlled Safety Study Of Ds-5565 For Treatment Of Pain Due To Fibromyalgia In Subjects With Chronic Kidney Disease.
Posted Date: Apr 7, 2017
- Investigator: Lesley Arnold
- Type of Study: Drug
The purpose of this study is to gather information and test the safety and tolerability of an investigational drug compared to a placebo (inactive substance) that may help treat pain caused by fibromyalgia in people with reduced kidney function.
Adults 18 Years Of Age And Older With Fibromyalgia And Reduced Kidney Function May Be Eligible To Participate
Kidney Disease, Fibromyalgia, Null, Null, Null
For More Information: